Notable Labs Research and Development Expenses 2013-2024 | NTBLQ
Notable Labs research and development expenses from 2013 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
Notable Labs Annual Research and Development Expenses
(Millions of US $) |
| 2023 |
$5 |
| 2022 |
$8 |
| 2021 |
$23 |
| 2020 |
$20 |
| 2019 |
$15 |
| 2018 |
$16 |
| 2017 |
$18 |
| 2016 |
$12 |
| 2015 |
$11 |
| 2014 |
$11 |
| 2013 |
$14 |
| 2012 |
$11 |
Notable Labs Quarterly Research and Development Expenses
(Millions of US $) |
| 2024-06-30 |
$2 |
| 2024-03-31 |
$2 |
| 2023-12-31 |
$3 |
| 2023-09-30 |
$-1 |
| 2023-06-30 |
$1 |
| 2023-03-31 |
$2 |
| 2022-12-31 |
$-12 |
| 2022-09-30 |
$6 |
| 2022-06-30 |
$7 |
| 2022-03-31 |
$7 |
| 2021-12-31 |
$6 |
| 2021-09-30 |
$5 |
| 2021-06-30 |
$7 |
| 2021-03-31 |
$5 |
| 2020-12-31 |
$6 |
| 2020-09-30 |
$5 |
| 2020-06-30 |
$5 |
| 2020-03-31 |
$5 |
| 2019-12-31 |
$4 |
| 2019-09-30 |
$4 |
| 2019-06-30 |
$4 |
| 2019-03-31 |
$3 |
| 2018-12-31 |
$3 |
| 2018-09-30 |
$4 |
| 2018-06-30 |
$3 |
| 2018-03-31 |
$6 |
| 2017-12-31 |
$6 |
| 2017-09-30 |
$5 |
| 2017-06-30 |
$3 |
| 2017-03-31 |
$4 |
| 2016-12-31 |
$4 |
| 2016-09-30 |
$2 |
| 2016-06-30 |
$2 |
| 2016-03-31 |
$4 |
| 2015-12-31 |
$2 |
| 2015-09-30 |
$5 |
| 2015-06-30 |
$2 |
| 2015-03-31 |
$2 |
| 2014-12-31 |
$3 |
| 2014-09-30 |
$3 |
| 2014-06-30 |
$3 |
| 2014-03-31 |
$2 |
| 2013-12-31 |
|
| 2013-09-30 |
|
| 2012-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.000B |
$0.000B |
|
Notable Labs Ltd. is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Notable Labs Ltd., formerly known as Vascular Biogenics Ltd., is based in FOSTER CITY, Calif.
|
